Stock Analiz

Syndax Pharmaceuticals Inc (SNDX) stock forecast and price target

Price $9.45 · data as of November 13, 2026

12-month price target

Average target$35.45
Upside / downside+275.2%
Analysts11
ConsensusStrong buy
Low $17.00Average $35.45High $57.00

Gold marker: average target · white marker: today’s price ($9.45)

Analyst ratings

Strong buy 2Buy 10Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.13+35.4%$316M
Next fiscal year
ends December 31, 2027
$-0.78+63.2%$459M
Next quarter
ends December 31, 2026
$-0.50+36.3%$96M
Quarter after
ends March 31, 2027
$-0.28+41.6%$96M

Consensus of the analysts covering Syndax Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 3 lowered.

Frequently asked questions

What is the Syndax Pharmaceuticals stock price target?

The average 12-month target from 11 analysts is $35.45, 275.2% above the current price of $9.45 Targets range from $17.00 to $57.00.

Is Syndax Pharmaceuticals a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 10 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Syndax Pharmaceuticals expected to earn?

Analysts expect EPS of $-2.13 for the fiscal year ending December 31, 2026 and $-0.78 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.